Miroslaw Bober - Hemostasis Today | Hemostasis News, Insights, Stories

Voices Science Insight Innovation

Headlines Hematology Health Medicine VTE ASH Plasma Donation

August, 2026

Miroslaw Bober

A Smarter Approach to Long-Term Anticoagulation After VTE - JTH

Jul 28, 2026, 22:25 | Science

A Smarter Approach to Long-Term Anticoagulation After VTE - JTH

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Satarupa…

Satarupa Choudhuri: Personalizing Anticoagulation Duration After VTE

Jul 4, 2026, 08:48 | Science

Satarupa Choudhuri: Personalizing Anticoagulation Duration After VTE

Satarupa Choudhuri, Deputy Clinical Director of Haematology, Rheumatology, Acite Oncology and Immunology at Northern Care…

Imran Khan: Balancing Benefit and Risk in Long-Term Anticoagulation

Jun 30, 2026, 09:29 | Science

Imran Khan: Balancing Benefit and Risk in Long-Term Anticoagulation

Imran Khan, Global Medical Leader at Pfizer, shared Amaia Irizar's post on LinkedIn: "Delighted to…

Alexander Cohen: How Long Should You Treat VTE?

Jun 20, 2026, 19:20 | Science

Alexander Cohen: How Long Should You Treat VTE?

Alexander Cohen, Consultant Physician at Guy’s and St Thomas’ NHS Foundation Trust, shared a post…

Miroslaw Bober: New 10-Year Dynamic Risk Prediction Models for rVTE and Bleeding

Jun 19, 2026, 09:24 | Science

Miroslaw Bober: New 10-Year Dynamic Risk Prediction Models for rVTE and Bleeding

Miroslaw Bober, Professor of Video Processing and Machine Learning at University of Surrey, shared a…

All: 5 Posts: 1 - 100

'

Jean-Jacques Kiladjian: Interferon-Alpha in Polycythemia Vera Balancing Efficacy and Autoimmune Risk

'

Bernd Montag: Stroke is a Race Against Time for Connected Health Systems

'

The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy

'

Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD

'

The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin

Aug 12, 2026, 06:09
Luis Tam։ New CDC Global Health Security Funding Opportunities
Aug 12, 2026, 06:09
Yan Leyfman: Curative Strategies and Precision Medicine in Sickle Cell Disease
Aug 12, 2026, 06:01
Sophie He: Exploring Manufacturing Scalability and Cell Separation
Aug 12, 2026, 05:54
Yuan Goessi: One Bleed Is One Too Many for a Lifetime of Haemophilia A
Aug 12, 2026, 05:47
Shehab Mohamed: Philadelphia Negative MPNs in AYA vs Older Adults in Qatar
Aug 12, 2026, 05:35
Burjor Langdana: Why Does Blast Traumatised Facial Tissue Keep Swelling and often Heal Badly
Aug 12, 2026, 05:22
Giuseppe Leone: Potential Causal Relationship between H. pylori and ITP
Aug 12, 2026, 03:54
Edina Cenko: Looking Beyond the Epicardial Coronary Arteries
Aug 12, 2026, 03:10
Ageing with Haemophilia – A Changing Clinical Landscape – EAHAD